Standard BioTools Inc. (LAB)
NASDAQ: LAB · Real-Time Price · USD
1.310
+0.030 (2.34%)
Aug 12, 2025, 11:35 AM - Market open
Catalent Market Cap
Standard BioTools has a market cap or net worth of $497.57 million as of August 12, 2025. Its market cap has decreased by -40.57% in one year.
Market Cap
497.57M
Enterprise Value
277.70M
1-Year Change
-40.57%
Ranking
Category
Stock Price
$1.31
Market Cap Chart
Since February 10, 2011, Standard BioTools's market cap has increased from $260.60M to $497.57M, an increase of 90.93%. That is a compound annual growth rate of 4.56%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 8, 2025 | 495.70M | -23.91% |
Dec 31, 2024 | 651.50M | 271.23% |
Dec 29, 2023 | 175.50M | 89.12% |
Dec 30, 2022 | 92.80M | -69.05% |
Dec 31, 2021 | 299.80M | -32.58% |
Dec 31, 2020 | 444.70M | 83.68% |
Dec 31, 2019 | 242.10M | -28.58% |
Dec 31, 2018 | 339.00M | 48.95% |
Dec 29, 2017 | 227.60M | 7.36% |
Dec 30, 2016 | 212.00M | -31.88% |
Dec 31, 2015 | 311.20M | -67.35% |
Dec 31, 2014 | 953.00M | -2.80% |
Dec 31, 2013 | 980.50M | 174.19% |
Dec 31, 2012 | 357.60M | 34.23% |
Dec 30, 2011 | 266.40M | 2.23% |
Feb 10, 2011 | 260.60M | - |
View and export this data all the way back to 2011. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 570.66B |
Johnson & Johnson | 419.17B |
AbbVie | 350.80B |
AstraZeneca | 229.47B |
UnitedHealth Group | 228.95B |
Novartis AG | 228.69B |
Abbott Laboratories | 228.64B |
Novo Nordisk | 222.88B |